ThiagoOliveiraMDMPH
Emergency Medicine • Boston, MACritical Care Medicine
Emergency Critical Care Medicine Fellow
Dr. Oliveira is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Boston, MA 02115Phone+1 617-732-5500
Education & Training
Boston University Medical CenterResidency, Emergency Medicine, 2016 - 2020
Boston University School of MedicineClass of 2016, MD, MPH
Certifications & Licensure
MA State Medical License 2016 - 2024- American Board of Emergency Medicine Emergency Medicine
- American Board of Emergency Medicine Internal Medicine-Critical Care Medicine
Publications & Presentations
PubMed
- 75 citationsRelationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117.Yehuda Z. Cohen, Julio C. C. Lorenzi, Lisa Krassnig, John P. Barton, Leah A. Burke
The Journal of Experimental Medicine. 2018-08-02 - 54 citationsRelationship between intact HIV-1 proviruses in circulating CD4+ T cells and rebound viruses emerging during treatment interruptionChing-Lan Lu, Joy A. Pai, Lilian Nogueira, Pilar Mendoza, Henning Gruell
Proceedings of the National Academy of Sciences of the United States of America. 2018-11-27 - 48 citationsCharacterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption.Line K. Vibholm, Julio C. C. Lorenzi, Joy A. Pai, Yehuda Z. Cohen, Thiago Y. Oliveira
Journal of Virology. 2019-04-03
Journal Articles
- Relationship Between Intact HIV-1 Proviruses in Circulating CD4+ T Cells and Rebound Viruses Emerging During Treatment InterruptionMichel C Nussenzweig, Thiago Y Oliveira, Marina Caskey, Proceedings of the National Academy of Sciences
- Article the Chromatin Reader ZMYND8 Regulates Igh Enhancers to Promote Immunoglobulin Class Switch RecombinationThiago Y Oliveira, Michel C Nussenzweig, ScienceDirect
- Combination Therapy with Anti-HIV-1 Antibodies Maintains Viral SuppressionMichael S Seaman, Katrina Millard, Marina Caskey, Michel C Nussenzweig, Roy M Gulick, Thiago Y Oliveira, Nature
- Join now to see all
Other Languages
- Spanish, Portuguese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
